D

Devyser Diagnostics AB
STO:DVYSR

Watchlist Manager
Devyser Diagnostics AB
STO:DVYSR
Watchlist
Price: 129 SEK -1.9% Market Closed
Market Cap: 2.1B SEK
Have any thoughts about
Devyser Diagnostics AB?
Write Note

Devyser Diagnostics AB
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Devyser Diagnostics AB
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
D
Devyser Diagnostics AB
STO:DVYSR
Revenue
kr169.3m
CAGR 3-Years
37%
CAGR 5-Years
29%
CAGR 10-Years
N/A
Biogaia AB
STO:BIOG B
Revenue
kr1.3B
CAGR 3-Years
20%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Revenue
kr814.5m
CAGR 3-Years
58%
CAGR 5-Years
44%
CAGR 10-Years
N/A
Vitrolife AB
STO:VITR
Revenue
kr3.6B
CAGR 3-Years
32%
CAGR 5-Years
21%
CAGR 10-Years
22%
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Revenue
kr25.4B
CAGR 3-Years
19%
CAGR 5-Years
16%
CAGR 10-Years
26%
BioArctic AB
STO:BIOA B
Revenue
kr616m
CAGR 3-Years
115%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
No Stocks Found

Devyser Diagnostics AB
Glance View

Market Cap
2.1B SEK
Industry
Biotechnology

Devyser Diagnostics AB engages in the development, manufacture and sale of kits for genetic testing in routine diagnostics. The company is headquartered in Hagersten, Stockholm. The company went IPO on 2021-12-10. The products are used for complex deoxyribonucleic acid (DNA) testing in the areas of hereditary diseases, oncology, and post-transplantation monitoring in order to diagnose genetic diseases and target cancer treatment. The firm has since its inception developed and launched almost 30 products for routine diagnostic use, including Devyser Thrombophilia assay as well as Devyser Resolution XY for analysis of chromosomes X and Y. Devyser Diagnostics’ products are sold directly to the end customer or through hired distributors. The firm provides its products in more than 45 countries.

DVYSR Intrinsic Value
124.25 SEK
Overvaluation 4%
Intrinsic Value
Price
D

See Also

What is Devyser Diagnostics AB's Revenue?
Revenue
169.3m SEK

Based on the financial report for Dec 31, 2023, Devyser Diagnostics AB's Revenue amounts to 169.3m SEK.

What is Devyser Diagnostics AB's Revenue growth rate?
Revenue CAGR 5Y
29%

Over the last year, the Revenue growth was 34%. The average annual Revenue growth rates for Devyser Diagnostics AB have been 37% over the past three years , 29% over the past five years .

Back to Top